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biological activity (6). Cannon and Youngs have developed a library of silver--based 66 antimicrobials, silver carbene complexes (SCCs), with enhanced stability over conventional 67 silver salts (10--14) . These molecules have demonstrated superior antimicrobial activity against 68 clinically relevant MDR pathogens including Pseudomonas aeruginosa, Burkholderia cepacia 69 complex species, Staphylococcus aureus, Klebsiella pneumoniae, and Acinetobacter baumannii, 70
both in vitro and in vivo (10--16) . These compounds also demonstrate potent antimicrobial 71 activity against biodefense pathogens Bacillus anthracis and Yersinia pestis (15) . Further, 72 polymeric nanoparticles loaded with these SCCs demonstrate superior in vivo antimicrobial 73 activity over parent molecules (15, 17) . These devices offer sustained release of the therapeutic 74 at the infection site and protect the silver ions from deactivation. As a result, in an acute 75 pneumonia model, mice treated with SCC--loaded nanoparticles exhibit increased survival and 76 lower bacterial burden with fewer and lower doses compared with treatment with 77 unencapsulated SCCs (17). Thus, development of novel molecules and delivery devices have 78 addressed the stability concerns and significantly improved the efficacy of silver, opening up 79 new avenues for the use of silver beyond topical therapy. 80
Toxicity of silver has always been a controversial topic. Several publications report silver to 81 be non--toxic, with argyria, a rare and irreversible pigmentation of the skin caused by silver 82 deposition, as the only reported side--effect (6, 18) . On the other hand, several reports have 83 demonstrated toxic side effects of silver in eukaryotic cells; claims that are underscored by the 84 anticancer activity of silver. While silver toxicity and chemotherapeutic activity have been 85 reported, little is known about the molecular mechanisms that contribute to silver toxicity. 86 towards eukaryotic cells, and are also responsible for the anticancer activity of silver 88 nanoparticles (5, 18--25) . These reports largely focus on the effect of size and surface coatings on 89 toxicity of metallic silver nanoparticles (19--27) . In general, pure silver nanoparticles demonstrate 90 lower toxicity to eukaryotic cells compared with ionic silver at comparable concentrations (27), 91 likely resulting from the gradual release of ionic silver from the nanoparticles upon surface 92 oxidation or dissolution. Kittler et al. (26) have established a direct correlation between 93 dissolution of nanoparticles and subsequent release of silver ions to toxicity towards eukaryotic 94 cells. While the individual toxicity caused by nanoparticles and silver ions has yet to be discerned, 95 generation of reactive oxygen species (ROS) has been implicated as a key underlying 96 mechanism of toxicity in both instances (28, 29) . ROS and the complementary cellular 97 antioxidant defense system are part of a complex cellular milieu that plays critical roles in several 98 biochemical processes (30). Silver disrupts the mitochondrial respiratory chain resulting in 99 overproduction of ROS, leading to oxidative stress, ultimately causing lipid peroxidation and 100 protein denaturation, interruption of ATP production, DNA damage, and induction of apoptosis 101 (31, 32) . Thus, ROS overproduction is one of the primary mechanisms responsible for inhibition 102 of cell proliferation and induction of cell death in cells exposed to silver. N--acetyl cysteine (NAC) 103 has been employed as an antioxidant to abrogate ROS generation and alleviate toxicity of silver 104 towards eukaryotic cells (29, 33--35) . However, the effects of anti--oxidants such as NAC on the 105 overall cellular health and cell metabolism are not well known. 106
We aim to develop non--toxic therapeutic strategies for eradication of multi--drug resistant 107 bacterial pathogens, particularly, pathogens responsible for lung infections. We have 108 extensively demonstrated the antimicrobial activity of silver against several pathogens that 109 result in lung infections, and here we evaluate the impact of silver--based compounds on host 110 cellular metabolism. Because we are interested in developing silver--based antimicrobials to 111 treat lung infections, we have evaluated the toxicity of silver in a human bronchial epithelial cell 112 line (16HBE). These studies are also relevant to environmental inhalation exposures to silver 113 particulates. We first confirmed that silver induces ROS in these 16HBE cells. Next, we have 114 determined the effect of three antioxidants, ascorbic acid (vitamin C), melatonin, and NAC, on 115 cell viability, and identified NAC as the only antioxidant that results in reduction of silver toxicity. 116
Further, we demonstrate the ability of NAC to reduce ROS generation in these cells without 117 affecting glutathione concentrations. Finally, exposure to silver disrupts cellular metabolism; 118 pre--incubation with NAC rescues the cells allowing maintenance of ATP production. 119
Additionally, the ability of NAC to rescue cells from silver toxicity is not limited to 16HBEs; we 120 have demonstrated similar effects in human dermal fibroblasts. Thus, NAC pre--incubation 121 suppresses ROS generation and maintains metabolic activity of the cell by sequestering silver 122 ions to abrogate silver toxicity. 123 124
Results. Silver induction of reactive oxygen species (ROS) and superoxide. Several 125
publications have demonstrated ROS generation by eukaryotic cells after exposure to silver. 126
Thus, we sought to verify the observation that silver acetate induces reactive oxygen species 127 and superoxide ions in a human bronchial cell line, 16HBE. Our results demonstrated a 128 significantly higher amount of ROS and superoxide ions within cells that are incubated with 129 silver acetate, at 8 and 24 hours, compared with cells that are not exposed to silver (Figure  1 ). was also evident in cells incubated with ascorbic acid. Cells incubated with ascorbic acid 137 demonstrated significantly higher antioxidant activity over cells only, and NAC incubated cells 138 (p ≤ 0.01), but not melatonin incubated cells. Surprisingly, NAC incubation did not result in 139 enhanced anti--oxidant activity, as no significant difference was observed between NAC 140 incubated cells and melatonin incubated cells, or cells incubated with media only. 141
Abrogation of silver acetate toxicity through pre--incubation with antioxidants. The effect of 142 antioxidant pre--incubation on silver acetate toxicity towards 16HBE cells is shown in Figure  3 143 (and Figure S1 in supplementary information). Cells pre--incubated with NAC demonstrated 144 significantly higher survival upon exposure to silver acetate at 8 and 24 hours. Cells pre--145 incubated with 10 mM NAC and up to 100 μg/mL silver acetate demonstrated significantly 146 higher survival over cells that were not pre--incubated with NAC (p ≤ 0.05). Similar results were 147 observed with cells pre--incubated with 5.0 and 7.5 mM NAC followed by incubation with silver 148 acetate at 50 and 75 μg/mL, respectively. Moreover, a dose response was observed; NAC pre--149 incubation at concentrations 1.0 mM or higher result in lower silver acetate toxicity. The lethal 150 dose at median cell viability (LD 50 ) values for cells exposed to silver acetate after pre--incubation 151 with 1, 2.5, 5, 7.5, and 10 mM NAC were 16, 27, 36, 63, and 60 μg/mL respectively, in contrast to 152 a LD 50 of 7.8 μg/mL silver acetate when cells were not pre--incubated with NAC. 153
Pre--incubation with neither ascorbic acid nor melatonin resulted in increased cellular survival 154 comparable to NAC. Pre--incubation with 7.5 and 10 mM ascorbic acid followed by up to 100 155 μg/mL silver acetate exposure resulted in significantly higher cell survival (p ≤ 0.05). Despite the 156 higher survival, however, the LD 50 values upon pre--incubation with ascorbic acid did not 157 appreciably change. Moreover, cells exposed to 50 μg/mL silver acetate after 10 mM NAC pre--158 incubation exhibited 86% survival compared with 22% survival upon pre--incubation with 10 mM 159 ascorbic acid (p ≤ 0.0001). Finally, melatonin pre--incubation did not alter the toxicity of silver pre--incubation also abrogated the toxicity of silver acetate against human dermal fibroblasts 166
( Figure  S3 , supplementary information). Thus, NAC was chosen as the molecule of interest for 167 further investigation. 168
Silver induction of reactive oxygen species (ROS) and superoxide. Figure 4 illustrates the 169 effect of NAC on silver acetate induced reactive oxygen species and superoxide ions. Pre--170 incubation with NAC suppressed the levels of ROS and superoxide seen after incubation with 171 silver acetate for 8 and 24 hours. Specifically, cells pre--incubated with 10 mM NAC, upon 172 exposure to silver acetate concentrations higher than 20 μg/mL, showed significantly lower ROS levels at 8 and 24 hours (p ≤ 0.001). Similarly, when cells were pre--incubated with 10 mM NAC, 174 superoxide levels were significantly lower at 8 and 24 hours after incubation with 10, 20, and 50 175 μg/mL silver acetate (p ≤ 0.001). Cells incubated with 100 μg/mL silver acetate showed 176 significantly lower superoxide levels at 8 hours when pre--incubated with NAC (p ≤ 0.01), but not 177 at 24 hours. Surprisingly, NAC pre--incubation initially induced ROS, which subsided after 8 178 hours, but had no effect on superoxide levels. 179
Glutathione concentrations after treatment with NAC. Because NAC is a known precursor of 180 glutathione, the effect of NAC pre--incubation on both oxidized and reduced glutathione 181 concentrations was determined. A dose response and significant reduction in the reduced 182 glutathione concentration was observed with increasing concentrations of silver, with or 183 without NAC pre--treatment ( Figure 5 ). However, this increase in GSH concentration was not 184 accompanied by an increase in GSSG levels, suggesting the absence of correlation between ROS 185 generation and oxidation of glutathione, after silver incubation. Further, NAC pre--treatment did 186 not result in any changes in total, oxidized, or reduced glutathione concentrations over cells not 187 pre--treated with NAC, with or without an insult from silver. 188 Analysis of total metabolite pool size and metabolite labeling patterns using gas 189 chromatography--mass spectroscopy. Disruption of the mitochondrial electron transport chain 190 has been linked to the ROS overproduction and cell death upon exposure to silver ions. To 191 further explore the metabolic effects of silver--induced ROS production, we evaluated glucose 192 consumption and its metabolism through the glycolysis pathway. Glucose consumption and 193 lactate production, the end product of glycolysis, were determined using a bioProfile BASIC 194 analyzer ( Figure  6 ). No significant difference was observed in glucose consumption and lactate production between cells that were pre--treated with 0 and 10 mM NAC; thus, incubation with 196 NAC did not significantly alter glucose consumption and lactate production. As expected, 197 treatment with increasing concentrations of silver acetate resulted in reduced glucose 198 consumption and lactate production. Next, we evaluated the effect of NAC incubation on the 199 oxidation of glucose--derived carbon in the TCA cycle. Levels of metabolites involved in the TCA 200 cycle were evaluated using GC--MS and normalized to control cells (not exposed to silver or NAC; 201 Figure 7 ). Cells exposed to silver alone demonstrated no change in lactate levels, but significantly 202 lower levels of TCA cycle intermediates including citrate, fumarate, and malate, as well as 203 glutamate and aspartate, surrogates for a--ketoglutarate and oxaloacetate, respectively, while 204 silver--exposed cells pretreated with NAC showed significantly less attenuation of TCA 205
intermediates. In particular, citrate, glutamate, fumarate, and malate levels were significantly 206 higher for NAC pre--incubated cells after exposure to 30, 40, 50, and 75 μg/mL silver acetate (p ≤ 207 0.05). Aspartate levels were significantly higher for NAC pre--incubated cells upon exposure to 208 50 and 75 μg/mL silver acetate (p ≤ 0.05). Finally, lactate levels were significantly higher for cells 209 pre--incubated with NAC and exposed to 50 μg/mL silver acetate only. In addition, pre--incubation 210 with NAC does not appreciably alter the labeling patterns of key metabolites ( Figure S4 , 211 supplementary information). Thus, these results demonstrated that exposure to silver acetate 212 resulted in mitochondrial stress that can be ameliorated by pre--incubation with NAC. 213
Determination of ATP content. NAC pre--incubation rescued the cells from the detrimental 214 effects of silver disruption of the TCA cycle. Next, the downstream effect of TCA cycle salvage 215 by NAC was measured in terms of ATP production to demonstrate the rescue of respiration in 216 these cells ( Figure  8 ). Cells pre--incubated with 10 mM NAC demonstrated significantly higher 217 ATP production upon exposure to silver compared with cells exposed to silver alone (p ≤ 0.0001). 218
Thus, NAC pre--incubation rescued cells from disruption of the TCA cycle and electron transport 219 chain to maintain ATP production at a comparable rate to the control group. 220
Antimicrobial activity of silver with or without NAC pretreatment. Antimicrobial activity of 221 silver acetate with or without pre--incubation with NAC was measured using a standard CLSI 222 broth--microdilution method ( Table 1 ). The minimum inhibitory concentration (MIC) of silver 223 acetate did not change when the bacteria were pre--incubated with 0 or 10 mM NAC, 224 demonstrating the selectivity of NAC to rescue eukaryotic cells without altering its antimicrobial 225 activity.
227
Discussion. The multiple mechanisms of action that make silver an attractive broad--spectrum 228 antimicrobial may also contribute to its toxicity towards eukaryotic cells. Several reports have 229 demonstrated that exposure to silver at low concentrations results in apoptosis, and exposure 230 at high concentrations results in necrosis (32, 35) . Cell death, via apoptosis or necrosis, after 231 silver exposure is often a result of ROS generation (32). 232
Mitochondria are considered the primary sources of ROS (30, 36) . Generation of ROS in the 233 mitochondria is a tightly regulated process that relies on the electron transport chain (ETC) for 234 ROS formation and cellular ROS scavengers such as enzymes, superoxide dismutase (SOD), 235 glutathione peroxidase (GP), thioredoxin (TRX), and peroxiredoxin (PRX), as well as antioxidants 236 such as, glutathione, for countering the generated ROS (30). Under physiological conditions, 237 glucose is converted to pyruvate during glycolysis, yielding two molecules of ATP, the energy 238 currency in the cell (37). The pyruvate molecules are then transported into the mitochondria, 239
where they are further broken down by the citric acid cycle to yield 36 molecules of ATP and ROS 240 (37). Until recently, ROS was generally regarded as a byproduct of this process. However, in the 241 last two decades, normal ROS levels have been implicated as second messengers in signal 242 transduction pathways (38). For example, mitochondrial ROS (mtROS) plays a critical role in 243 regulation of apoptosis, stem cell differentiation, autophagy, as well as cellular and tissue level 244 inflammation (39). Upon exposure to chemicals including Ag + ions, an imbalance of ROS 245 generation results in oxidative stress causing damage to all three classes of biologic 246 macromolecules --lipids, proteins, and nucleic acids (36, 38) . High levels of oxidative stress 247 induce cell death via one of two pathways: apoptosis or programmed necrosis (40). 248
Our results demonstrate a significant increase in the ROS and superoxide levels in human 249 cells after exposure to silver (Figure  4 ). The downstream effects of ROS are complex, including 250 activation of several pathways that ultimately lead to cell death (30, 36, 40) . Mitochondrial DNA 251 is highly susceptible to oxidative damage by mtROS due to its close proximity and a lack of 252 protection by histones (36). To that end, the level of oxidatively modified bases in mtDNA has 253 been found to be 10--20 fold higher than in nuclear DNA (36). In addition, nucleotide binding 254 domain--leucine rich repeat (NLR) proteins recognize damage associated molecular patterns 255 (DAMPs) in the mitochondrial DNA to initiate pyroptosis, a mode of induced cell death (39). 256
Concurrently, mtROS stimulates lipid peroxidation, ultimately leading to disruption of 257 mitochondrial membrane potential and mitochondrial calcium buffering capacity (36). ROS 258 mediated opening of Ca 2+ dependent mitochondrial permeability transition (MPT) pore results 259 in ATP depletion, ultimately leading to necrosis (36, 41) . MPT induction in part of the 260 mitochondrial population, leaving the unperturbed mitochondria to produce sufficient ATP, results in caspase mediated apoptosis (36). These observations are consistent with our results; 262 exposure to silver results, ROS induced oxidative stress leading to depletion of ATP ( Figure  8 ) 263
and cell death. 264
The surplus of superoxide and ROS interacts with critical proteins also resulting in activation 265 of pathways that lead to cell death. Superoxide damages and deactivates iron--sulfur proteins 266 such as aconitases (30). Superoxide rapidly reacts with the [4Fe--4S] to yield a catalytically 267 inactive [3Fe--4S] protein, ultimately blocking the conversion of citrate to isocitrate by 268 aconitases in the TCA cycle (30, 36) . These effects are further exacerbated by the production of 269 Fe 2+ and hydrogen peroxide upon interaction between superoxide and thiol containing proteins. 270
Released hydrogen peroxide can cause further oxidative damage to DNA, lipids, and proteins 271 (36, 38) . This inhibition of aconitases after exposure to ROS is typically associated with 272 accumulation of citrate (30); however, our results show a reduction in citrate levels. This 273 depletion of citrate can be attributed to the inactivation of pyruvate dehydrogenase kinase after 274 exposure to mtROS (30). Pyruvate dehydrogenase kinase 2 (PDHK2), a major player of the 275 pyruvate dehydrogenase complex (PDC) is responsible for catalytic conversion of pyruvate into 276 acetyl--coA, a precursor of citrate in the TCA cycle. The mechanism of deactivation of these 277 enzymes is not limited to the mitochondrial ROS; these proteins, including pyruvate 278 dehydrogenase (PDH), can also be inhibited upon interaction with metal ions (42). Samikkannu 279 et al. (42) have demonstrated inhibition of PDH after interaction with metal ions, as well as ROS. 280
Thus, the combined deactivation of these two enzymes results in depletion of acetyl--coA, 281 citrate, and isocitrate levels, key metabolites for the TCA cycle, ultimately resulting in disruption 282 of the TCA cycle. The downstream effects of the loss of citrate directly impacts the TCA cycle, 283 as demonstrated by reduced levels of downstream metabolites, glutamate, aspartate, 284 fumarate, and malate (Figure  7) . In response to this breakdown, there is a significant reduction 285 in the ATP produced during the process, after exposure to silver (Figure  8) . kinase isoform (PMK2) forces activation of the PPP (30). This shift to the PPP, which is 298 responsible for generating majority of the NADPH, is key defense mechanism activated by the 299 cell in response to the oxidative damage. The products of the PPP are subsequently shuttled 300 back into the glycolytic pathway. In addition to activation of the PPP, PMK2 is also thought to 301 play a critical role in the antioxidant defense system by diverting 3--phosphoglycerate to 302 glutathione synthesis, via the phosphoserine synthesis pathway (30, 44) . Activation of this 303 pathway should result in an increase in the reduced glutathione (GSH) levels, which further 304 deactivates ROS to form the oxidized glutathione (GSSG) (38). Our results indicate a reduction 305 in the reduced form of glutathione after exposure of human cells to silver ( Figure 5 ) and are 306 consistent with the results obtained by Arora et al. after exposing cells to silver nanoparticles 307 (32). However, the expected increase in the GSSG levels is not observed. This unexpected 308 behavior is likely caused by the high affinity of silver ions towards the thiol groups present on 309 glutathione. The silver glutathione complex blocks the ability of GSH to neutralize ROS. Thus, 310 silver associated toxicity is a direct consequence of a combination of silver interaction with 311 cellular components and ROS generation. These two processes are closely related, often 312 complementary, and their individual effects cannot be separated. The downstream response of 313 all these mechanisms results in a Warburg--like effect, where the glucose consumed by the cells 314
is not completely oxidized and is secreted as lactate ( Figure  6 ). For use of silver as an effective 315 antimicrobial, we must address all of these toxicity mechanisms without altering its 316 antimicrobial activity. 317
The multiple cell--death mechanisms activated by ROS generated by exposure to silver have 318 garnered attention of several researchers (28, 29, 32, 34) . Antioxidants have been explored to 319 check the ROS generated after exposure to metal (31). N--acetyl cysteine (NAC) is one of the 320 most common antioxidants investigated to abrogate the toxicity of silver, as well as other metal 321 ions (29, 33--35, 45) . Several groups have demonstrated successful rescue of mammalian cells 322 upon pre--exposure to NAC followed by exposure to metal ions (33, 35, 44, 45) . NAC pre--323 incubation results in significant ROS reduction upon exposure to silver (Figure  4 ). However, it is 324 unclear if the reduction in the ROS levels is a direct consequence of the ROS scavenging activity 325 of NAC or a downstream effect of silver--NAC interactions. In order to elucidate the mechanism 326 of rescue and develop a future potential therapeutic that can ameliorate toxicity of silver--based 327 therapeutics such as, silver antimicrobial bandages, we investigated several antioxidants and 328 their ability to rescue mammalian cells from silver toxicity. Of all the evaluated antioxidants, 329
NAC is the only antioxidant that demonstrates significant rescue (Figure  3,  Supplementary  Fig.  330 S1, S2, and S3). Melatonin, which demonstrates only slightly lower antioxidant capacity 331 compared with NAC, does not result in rescue of cells from silver associated toxicity. Although 332 ascorbic acid has a higher antioxidant capacity than NAC, ascorbic acid failed to rescue the cells 333 from silver toxicity. Indeed, among the antioxidants tested, NAC exclusively rescues cells from 334 silver associated toxicity; the ROS levels in cells pre--incubated with NAC followed by up to 50 335 μg/mL silver are similar to the negative controls, cells that received neither NAC nor silver. The 336 failure of ascorbic acid to rescue silver--exposed cells suggests that antioxidant activity is not the 337 only mechanism through which NAC pre--treatment resulted in lower ROS levels. 338
Unique structural properties position NAC to abrogate the multiple toxicity mechanisms 339 induced by silver cations. NAC is a precursor for glutathione, however, the glutathione levels of 340 cells incubated with NAC are similar to those of control cells. Thus, the reduction in ROS is not 341 directly influenced by glutathione. We hypothesized that the thiol groups present on NAC bind 342 with silver, which would prevent it from binding with DNA, and generating ROS. We confirmed 343 the ability of NAC to bind with silver using 1 H nuclear magnetic resonance (NMR) spectrometry 344 ( Figure  S5 ). The hydrogen atoms associated with the primary carbon on NAC demonstrate a 345 distinct shift (at 2--3 ppm) in the signal in the presence of silver. Further, NAC and silver self--346 assemble into a hydrogel, confirming the interaction between NAC and silver. Similar NAC--347 based hydrogels after interaction with silver, gold, and copper have been reported by Casuso et 348 al (46) . In addition, NAC is known as an antiapoptotic agent, and inhibits several apoptotic pathways including, NF--κB, MEK/ERK, and the JNK pathway, promoting cell survival (47, 48) . 350
The downstream effect of NAC treatment is underscored by the significant improvement in the 351 metabolic state of the cell. Cells treated with NAC demonstrate normal levels of TCA cycle 352 metabolites after silver exposure. These cells also demonstrate normal lactate production and 353 ATP levels. The ability of NAC to rescue eukaryotic cells is not limited to bronchial epithelial cells; 354 human dermal fibroblasts also demonstrate similar cell viability patterns. Finally, the ability of 355 NAC to rescue eukaryotic cells from silver associated cell death does not affect the antimicrobial 356 activity of silver; when P. aeruginosa and MRSA isolates were pre--exposed to 10 mM NAC, the 357 MIC of AgAc was identical to that of NAC--free AgAc (Table 1) . Moreover, NAC is frequently used 358 as a mucolytic in patients suffering from cystic fibrosis (CF) (49), chronic obstructive pulmonary 359 disorder (COPD) (50), and chronic bronchitis (51, 52). The benefits of NAC have led to its 360 inclusion in The World Health Organization's (WHO) list of essential medicines (53). Thus, a 361 silver/NAC combination presents a unique therapeutic strategy that can effectively eradicate 362 bacterial infections without causing toxicity to eukaryotic cells. 363
In conclusion, silver is a potent, FDA approved, antimicrobial that is widely used to eradicate 364 infections associated with MDR pathogens. We report here a novel mechanism that results in 365 rescue of mammalian cells from silver associated toxicity without altering its antimicrobial 366 activity. Cells incubated with silver demonstrate high levels of ROS, which causes disruption of 367 the TCA cycle and reduction in ATP production, ultimately leading to cell death via apoptosis or 368 necrosis. On the other hand, cells pre--incubated with NAC followed by silver do not demonstrate 369 signs of oxidative stress, show a normal metabolic state, as well as ATP production, which translates to lower silver toxicity. Thus, the silver/NAC combination has tremendous potential 371 as a future therapeutic with potent antimicrobial activity with a large therapeutic window. Distilled deionized water (DH 2 O) was obtained from a Milli--Q biocel system (Millipore, Billerica, 390 MA) and sterilized in an autoclave. All the above chemicals were used without further 391 purification.
Gruenert (University of California, San Francisco, CA) are a human bronchial epithelial cell line 394 transformed with SV40 large T--antigen using the replication--defective pSVori plasmid (54). 395 16HBEs were used between passages of 20 and 40 for all experiments. 16HBE cells were cultured 396 in Minimum Essential Medium (MEM) with Earle's Balanced Salts and non--essential amino acids 397 supplemented with 10% fetal bovine serum (FBS), 1% L--glutamine, and 1% penicillin--398 streptomycin (P/S) solution at 37°C in an incubator (5% CO 2 , 100% RH), unless otherwise noted. 399
When the cells reached 90--95% confluency, they were harvested by trypsinizing and sub--400 cultured. 401
Silver induction of reactive oxygen species (ROS) and superoxide. Cellular ROS and 402
superoxide levels were measured in 16HBE cells using a Cellular ROS/Superoxide Detection 403
Assay Kit according to manufacturer's recommended protocol. Briefly, cells were seeded at a 404 density of 25,000 cells/well in a black wall/clear bottom 96--well plate and incubated for 24 h as 405 described above. Next, the feeding media was aspirated and cell were incubated with fresh 406 media supplemented with or without 10 mM NAC for 2 h. Finally, the NAC solution was removed 407 and cells were incubated with 100 μL of 0, 10, 20, 50, or 100 μg/mL silver acetate containing 1X 408 ROS/Superoxide detection mix. Upon staining, the fluorescence signal from the two fluorescent 409 dyes, green signal from ROS detection probe (Ex/Em = 490/525 nm) and orange signal from 410 superoxide detection probe (Ex/Em = 550/620 nm), were quantified using a BioTek Instruments 411
Cytation 5 Multimode Reader at 0, 4, 6, 8, and 24 h. The fluorescence signal was normalized to 412 the drug free controls (0 mM NAC + 0 μg/mL silver acetate). All experiments were performed 413 with 6 technical replicates and a minimum of 2 biological replicates.
Activity of antioxidants.
Antioxidant activity of NAC, ascorbic acid, and melatonin was 415 measured using a Total Antioxidant Capacity Assay Kit according to manufacturer's 416 recommended protocol. A standard curve correlating the Trolox concentration to the 417 antioxidant capacity was generated according to manufacturer's protocol. NAC, ascorbic acid, 418 and melatonin were dissolved at 10mM concentration in distilled -deionized water (d. d. water) 419 and serially diluted. All experimental and standard solutions were protected from light, 420 incubated with colorimetric Cu +2 probe for 1.5h with constant shaking and absorbance was 421 measured at 570 nm using a BioTek Cytation 5 Multimode Reader. The antioxidant capacity of 422 test solutions, NAC, ascorbic acid, and melatonin were then correlated to the standard curve 423 and presented as a function of the final Trolox concentration. Next, the antioxidant capacity of 424 NAC, ascorbic acid, and melatonin pre--incubated 16HBE cells was also measured. Two million 425 16HBE cells were seeded into each well of a 12--well plate and incubated overnight as described 426 above. The feeding media was then replaced with fresh feeding media or media containing 10 427 mM NAC, ascorbic acid, or melatonin. After a 2 h incubation with the antioxidants, cells were 428 washed with cold PBS, re--suspended in 100 μL d. d. water, homogenized by pipetting, and 429 incubated on ice for 10 min. Finally, the insoluble cell debris was removed by centrifugation and 430 the supernatant analyzed as described above to determine the total antioxidant capacity. All 431 experiments were performed with 4 technical replicates and two biological replicates. 432
Abrogation of silver acetate toxicity through pre--incubation with antioxidants. Toxicity of 433 silver acetate with or without pre--incubation with antioxidants was assessed on 16HBE cells 434 using an alamarblue® Cell Viability Assay according to manufacturer's recommended protocol. 435
Cells were seeded at a density of 25,000 cells/well in a 96--well plate and incubated overnight as 436 described above. At 24 h, media was aspirated, and cells were pre--incubated with 80 µL of 0, 437 0.01, 0.1, 1.0, 2.5, 5, 7.5, and 10 mM concentrations of NAC, ascorbic acid, and melatonin for 2 h. 438
Next, the antioxidant supplemented media was replaced with 100 µL feeding media containing 439 0, 10, 20, 30, 40, 50, 75 , and 100 µg/mL silver acetate. Alamarblue test reagent was added to 440 each well, and the plates were incubated as described above. At 8 and 24 h timepoints, 441 absorbance was measured at 570 and 600 nm, normalized to media only controls, and analyzed 442 per manufacturer's instructions. All experiments were performed with 6 technical replicates and 443 3 biological replicates. These results were verified using an CyQUANT® Cell Proliferation Assay 444
Kit (Supplementary Information). 445
Glutathione concentrations after pretreatment with NAC. Glutathione levels in 16HBE cells 446
pre--incubated with NAC were determined using a GSH/GSSG Ratio Detection Assay Kit II 447 according to manufacturer's recommended protocol. Five million 16HBE cells were seeded in 448 each well of a 6--well plate as described above. At 24 h, the feeding media was replaced with 449 fresh feeding media supplemented with or without 10 mM NAC and incubated for 2 h. Next, cells 450 were incubated with 0, 10, and 100 µg/mL silver acetate for 1 h and glutathione levels measured. 451
Briefly, cells were washed with cold PBS, re--suspended in 300 µL ice cold Mammalian Cell Lysis 452
Buffer and homogenized by pipetting. The cell lysate was then centrifuged to remove the cell 453 debris and the supernatant was carefully collected and deproteinized using a Deproteinizing 454 Sample Kit. The deproteinized samples were then diluted using lysis buffer, mixed with 455 glutathione (GSH) and total glutathione (TGAM or GSH + GSSG) assay probes, incubated for 60 456 minutes protected from light, and fluorescence signal measured at Ex/Em = 490/520 nm using a 457
BioTek Cytation 5 Multimode Reader. The fluorescence signal from the experimental values and firefly luciferase at manufacturer recommended concentrations was prepared. Next, 10 µL 503 of standard ATP solution or cell lysate was mixed with 90 µL standard reaction mixture in a 96--504 well white bottom plate and luminescence was measured at 560 nm. Background luminescence 505 was subtracted from all readings and the data were normalized to drug free controls. 506
Antimicrobial activity of silver. Antimicrobial activity of silver was evaluated against laboratory 507 and clinical isolates of Pseudomonas aeruginosa (PA O1, PA M57--15, PA HP3, and PA14) as well 508
as methicillin--resistant Staphylococcus aureus (MRSA; USA 300, MRSA 0606, MRSA 0638, and 509 MRSA 0646), with or without pre--incubation with NAC. Frozen stocks of bacteria were struck 510 onto TSA plates and allowed to grow for 18--24 h at 37°C. A single colony was used to inoculate 511 5 mL MH broth and grown to an OD 650 = 0.40 at 37°C on an orbital shaker. Next, the bacteria 512 were centrifuged at 2500 rpm for 15 m at 4°C, supernatant aspirated, and bacterial pellets were 513 re--suspended in 2 mL MH broth supplemented with 0 or 10 mM NAC. Bacterial suspension was 514 then incubated at 37°C with orbital shaking for 2 h, centrifuged again to remove the NAC 515 solution, and re--suspended in NAC free MH broth to OD 650 = 0.4. Finally, minimum inhibitory 516 concentrations (MIC) against silver acetate were determined using standard Clinical and 517 Laboratory Institute (CLSI) broth--microdilution method. Briefly, bacterial suspension at a 518 concentration of 5E5 colony forming units (CFU) per milliliter was incubated with a silver acetate 519 at a final concentration of 0.13, 0.25, 0.5, 1, 2, 4, 8, 16, and 32 µg/mL silver acetate at 37°C for 18--520 24h, under static conditions. The MIC was determined as the lowest concentration resulting in 521 no bacterial growth upon visual inspection. All experiments were performed in triplicate. 522
Statistics. All data were analyzed using GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, 523 CA). A two--way analysis of variance (ANOVA) followed by a post hoc Sidak's or Tukey's test with 524 multiple comparisons between means at each concentration of silver acetate was used to 525 determine the significant difference. Additionally, non--linear regression was used to deduce the 526 lethal dose at median cell viability (LD 50 ) for cell viability assays. A p ≤ 0.05 was considered 527 significantly different. 
